According to the TechSci Research report titled “Global Antimicrobial Susceptibility Testing Market – Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the global antimicrobial susceptibility testing market is expected to experience a high compound annual growth rate (CAGR) throughout the forecast period. This growth is attributed to the increasing prevalence of certain hospital-acquired diseases worldwide during the forecast period.
Antimicrobial susceptibility testing (AST) is a laboratory technique utilized to assess the effectiveness of antibiotics against specific microorganisms. With the rise of antibiotic resistance, there is a growing demand for accurate and rapid antimicrobial susceptibility testing. For example, methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial strain commonly treated for staph infections. MRSA emerged due to the widespread use of antibiotics, particularly methicillin, which exerted selective pressure, leading to bacterial resistance. To address the challenge of antibiotic-resistant bacteria like MRSA, healthcare providers are adopting strategies to reduce antibiotic use and prevent infection spread by relying more on antimicrobial susceptibility testing. This trend is expected to fuel the growth of the global antimicrobial susceptibility testing market during the forecast period. Additionally, advancements in antimicrobial susceptibility testing technology contribute significantly to the market’s expansion. For instance, the Accelerate Pheno system uses automated fluorescence in situ hybridization technology with morphokinetic cellular analysis to rapidly identify pathogens and test their susceptibility to antimicrobials in positive blood cultures.
Browse over XX Market Data Figures and spread through XX Pages and an in-depth TOC on “global antimicrobial susceptibility testing market.” – https://www.techsciresearch.com/report/antimicrobial-susceptibility-testing-market/15570.html/
Furthermore, the increasing incidence of hospital-acquired diseases across various regions of the world is anticipated to drive the growth of the global antimicrobial susceptibility testing market during the forecast period. Urinary tract infections (UTI), surgical site infections (SSI), bloodstream infections, pneumonia, Clostridium difficile infection (CDI), and MRSA are some common infections acquired by patients while receiving treatment in healthcare facilities such as hospitals or clinics. According to a report published by Patient Care Link on Healthcare-Acquired Infections (HAIs) in 2022, the Centers for Disease Control (CDC) estimates that in American hospitals alone, HAIs account for approximately 1.7 million infections and 99,000 associated deaths each year. Urinary tract infections accounted for 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%). The emergence of these infections further increases the demand for antimicrobial susceptibility testing in the market to enable early prevention and treatment.
Moreover, various governments are taking initiatives to make antimicrobial susceptibility testing more affordable for the population, contributing to the impressive growth of the global antimicrobial susceptibility testing market during the forecast period. Governments are also providing funding for research and development of new AST products and technologies. For example, the UK government has allocated EUR 10 million to fund research on new AST technologies to combat antimicrobial resistance (AMR). Similarly, the US government is providing funding through the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) to develop new AST products.
However, the complex regulatory framework for antimicrobial susceptibility testing and the high cost of automated laboratory infrastructure are expected to slow down the market’s growth in the coming years.
The global antimicrobial susceptibility testing market is segmented based on product, technique, application, end-user, company, and region. The market’s product segment includes manual tests (mic strips, susceptibility testing disks, susceptibility plates), automated instruments, and consumables & media. Manual tests are expected to dominate the market during the forecast period due to their ease of availability and lower cost compared to automated testing.
Some of the major companies operating in the global antimicrobial susceptibility testing market include:
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- bioMerieux, Inc.
- Creative Diagnostics
- Hi-Media Laboratories Pvt. Ltd.
- PerkinElmer, Inc.
- ELITech Group SAS
- Hoffmann-La Roche Ltd.
- Accelerate Diagnostics, Inc.
Customers can also request for 10% free customization on this report.
“Certain regions are expected to dominate the demand for antimicrobial susceptibility testing in the world. Growing use of commercial rapid testing systems for fungal analysis increasing public and private investments for improving the quality of antimicrobial susceptibility testing in the market is expected to register a lucrative growth to global antimicrobial susceptibility testing market in the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Antimicrobial Susceptibility Testing Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates) Automated Instruments, and Consumables & Media), By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, and Others), By Application (Drug Development, Susceptibility Testing, and Others), By End User (Hospitals, Diagnostic Laboratories, BioTechnique & Pharmaceutical Companies, and Others), By Region and Competition”, has evaluated the future growth potential of global antimicrobial susceptibility testing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global antimicrobial susceptibility testing market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=15570
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com